Literature DB >> 6894976

Correlation of CT scanning and pathologic features of ophthalmic Graves' disease.

S L Trokel, F A Jakobiec.   

Abstract

Correlating the CT scan features of patients with orbital Graves' disease with histopathologic observations allows one to focus more specifically on the distinguishing features of this disease with future research implications. Both CT scanning and pathologic studies have shown clearly that the extraocular muscles are the primary focus of the disease. Swelling of the extraocular muscles generally occurs within their bellys with sparing of the tendons. This contrast with idiopathic inflammation of the muscles or myositis, which tends to involve the tendon as well. All of the associated findings in orbital Graves' disease probably flow from the enlarged volume of the extraocular muscles: proptosis, bowing of the medial lamina papyracea to accommodate the swollen belly of the medial rectus muscle, venous engorgement from stasis induced by direct compression of the orbital venous drainage, conjunctival and lid swelling, and lacrimal gland enlargement. Both radiographic and pathologic changes in the orbital fat are secondary and comparatively insignificant. While there appears to be no selective inflammation of the optic nerve meninges or the perineural connective tissues, enlargement of the extraocular muscle bellys where they converge at the crowded orbital apex brings about compression of the optic nerve, impairs its function, and causes visual decrease. Lymphocytic and plasmacytic infiltration along with edema within the endomysium of the extraocular muscles leads to the activation of fibroblasts with the production of acid mucopolysaccharides and progressive fibrosis. It is not known what attracts the lymphocytes to the extraocular muscles, why certain extraocular muscles are affected preferentially, why the disease may be asymmetrically unilateral, and whether a defect in T cell or B cell functions (or both) is immunologically at fault.

Entities:  

Mesh:

Year:  1981        PMID: 6894976     DOI: 10.1016/s0161-6420(81)34993-8

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  48 in total

1.  Volumetric analysis of CT orbital images.

Authors:  L Lutzemberger; O Salvetti
Journal:  Med Biol Eng Comput       Date:  1998-11       Impact factor: 2.602

2.  Unilateral proptosis: the role of medical history.

Authors:  N Kamminga; N M Jansonius; J W R Pott; T P Links
Journal:  Br J Ophthalmol       Date:  2003-03       Impact factor: 4.638

3.  Reversal of dysthyroid optic neuropathy following orbital fat decompression.

Authors:  M Kazim; S L Trokel; G Acaroglu; A Elliott
Journal:  Br J Ophthalmol       Date:  2000-06       Impact factor: 4.638

Review 4.  Autoimmunity in Graves' ophthalmopathy: a review.

Authors:  A P Weetman
Journal:  J R Soc Med       Date:  1989-03       Impact factor: 5.344

5.  Secretory IgA and lysozyme in tears of patients with Graves' ophthalmopathy.

Authors:  H A Khalil; R J De Keizer; V M Bodelier; A Kijlstra
Journal:  Doc Ophthalmol       Date:  1989-08       Impact factor: 2.379

6.  Recurrent external ophthalmoparesis during hormonal therapy after thyroid ablation. Case report.

Authors:  F Ferracci; F Conte; B Marini; G Fassetta
Journal:  Ital J Neurol Sci       Date:  1997-08

7.  Update on advanced imaging options for thyroid-associated orbitopathy.

Authors:  Michael P Rabinowitz; Jacqueline R Carrasco
Journal:  Saudi J Ophthalmol       Date:  2012-10

8.  Enhanced-depth optical coherence tomography for imaging horizontal rectus muscles in Graves' orbitopathy.

Authors:  Nathanael U Häner; Muriel Dysli; Mathias Abegg; Martin S Zinkernagel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-06-07       Impact factor: 3.117

Review 9.  Graves' ophthalmopathy.

Authors:  B W Fleck; A D Toft
Journal:  BMJ       Date:  1990-05-26

10.  Extraocular muscle changes in experimental orbital venous stasis: some similarities to Graves' orbitopathy.

Authors:  E Saber; J McDonnell; K M Zimmermann; J E Yugar; S E Feldon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-05       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.